25% activation probability · No activation evidence yet
Breadth0%
Bridge40 / Weak
Decision Frame
Why it matters, what confirms, what breaks
Why It Matters
Live thesis
This cluster focuses on companies specializing in the development and commercialization of innovative cell therapies for cancer and other medical conditions.
Decision context
Live breadth at 0% with LEGN leading
Best bridge
PGR to AGG is the strongest transmission path right now.
What Confirms
PGR -> AGG
weak bridge transmission across the current structure.
PGR -> EMB
weak bridge transmission across the current structure.
LEGN
LEGN is the current leadership name for Cell Therapy, carrying the highest structural influence in the live cluster.
What Breaks
Leader dependence
LEGN still carries the highest influence in the live cluster.
Breadth compression
Watch for participation slipping below 30%.
Bridge failure
2 cross-asset bridge(s) are available as confirmation checks.